P U Feig, P Hirszel, M A Galen, E Rosenworcel, L G Raisz
{"title":"Hemodialysis in the treatment of life-threatening hyperphosphatemia.","authors":"P U Feig, P Hirszel, M A Galen, E Rosenworcel, L G Raisz","doi":"10.3109/08860228209050818","DOIUrl":"https://doi.org/10.3109/08860228209050818","url":null,"abstract":"A case of phosphate intoxication is reported in which hemodialysis was used to reverse life-threatening hyperphosphatemia.","PeriodicalId":79208,"journal":{"name":"Clinical and experimental dialysis and apheresis","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1982-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3109/08860228209050818","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18166741","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Red blood cell susceptibility to hydrogen peroxide (H2O2) lysis in chronic hemodialysis patients.","authors":"R K Albright, R P White","doi":"10.3109/08860228209049855","DOIUrl":"https://doi.org/10.3109/08860228209049855","url":null,"abstract":"<p><p>To assess susceptibility to oxidant induced membrane damage, the red blood cell H2O2 hemolysis test was performed in fifty-three chronic hemodialysis patients. Uremic red blood cells were not more susceptible to 2.5% H2O2 lysis pre or postdialysis than were control red blood cells. Oxidant induced red blood cell lysis is a function of the strength of the oxidant and not a testable intrinsic defect of the uremic red blood cell.</p>","PeriodicalId":79208,"journal":{"name":"Clinical and experimental dialysis and apheresis","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1982-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3109/08860228209049855","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18196624","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Compartmental syndrome following subclavian vein hemodialysis.","authors":"A J Vaz","doi":"10.3109/08860228209050810","DOIUrl":"https://doi.org/10.3109/08860228209050810","url":null,"abstract":"<p><p>Compartmental syndrome occurred in a patient when the subclavian vein was used for hemodialysis. This complication has not yet been reported in subclavian vein hemodialysis. Compartmental syndrome has been more commonly reported as affecting the lower extremities. Increased edema formation due to venous congestion in a tight compartment is the cause for this syndrome. Prompt recognition and treatment can prevent serious complications. The incidence of compartmental syndrome will increase, as both the subclavian vein and internal jugular vein area used more frequently for hemodialysis.</p>","PeriodicalId":79208,"journal":{"name":"Clinical and experimental dialysis and apheresis","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1982-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3109/08860228209050810","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35220364","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
C Charytan, B S Spinowitz, R A Golden, J H Rascoff
{"title":"Continuous ambulatory peritoneal dialysis: establishment and growth of a program in a large metropolitan area.","authors":"C Charytan, B S Spinowitz, R A Golden, J H Rascoff","doi":"10.3109/08860228209049849","DOIUrl":"https://doi.org/10.3109/08860228209049849","url":null,"abstract":"<p><p>We describe our experience at the Booth Memorial Medical Center with the development and growth of a Continuous Ambulatory Peritoneal Dialysis program. This initial experience includes the training and close follow-up of 41 patients with End Stage Renal Disease over a period of 15 months. The status of our program with respect to medical complications encountered and their management is described. Our results, in terms of biochemical control, success with training, and patient satisfaction with CAPD are outlined.</p>","PeriodicalId":79208,"journal":{"name":"Clinical and experimental dialysis and apheresis","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1982-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3109/08860228209049849","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18196619","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"CAPD peritonitis in perspective.","authors":"C Charytan, B S Spinowitz","doi":"10.3109/08860228209049848","DOIUrl":"https://doi.org/10.3109/08860228209049848","url":null,"abstract":"","PeriodicalId":79208,"journal":{"name":"Clinical and experimental dialysis and apheresis","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1982-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3109/08860228209049848","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18196618","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Hemodynamic analysis of the ischemic complications of arteriovenous fistulas.","authors":"W A Hyman","doi":"10.3109/08860228209049853","DOIUrl":"https://doi.org/10.3109/08860228209049853","url":null,"abstract":"<p><p>The steal syndrome and its concomitant ischemic complications have long been known to occur in some patients following the construction of various types of access fistulas. A hemodynamic analysis of the flow at a bifurcation provides the basis for understanding the conditions which leads to steal. The analysis also suggests a method for assessing the potential for steal and supports the concept of banding of a fistula as a control measure.</p>","PeriodicalId":79208,"journal":{"name":"Clinical and experimental dialysis and apheresis","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1982-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3109/08860228209049853","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18196622","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Enhancement of clearances by activated charcoal in an in vitro model of peritoneal dialysis.","authors":"H L Lang, K D Nolph, T J McGary","doi":"10.3109/08860228209050816","DOIUrl":"https://doi.org/10.3109/08860228209050816","url":null,"abstract":"<p><p>The use of sorbents in dialysate to increase solute clearances in continuous ambulatory peritoneal dialysis (CAPD) was investigated. With in vitro simulations of CAPD, the kinetics of irreversible binding of creatinine to activated charcoal were assessed. Cellulose dialyzer fibers were submerged in two liters of dialysate for 3-8 hour exchanges. Perfusate was pumped single pass through the fibers. Commercial dialysates with 1.5% and 4.25% dextrose as an osmotic agent were controls. Experimental exchanges contained either large or small particles of activated charcoal. Unencapsulated and collodion encapsulated large particles were also studied. From the perfusate side, creatinine, clearance and mass transfer were determined; dialysate/perfusate ratios (D/P) of free creatinine concentrations were assessed. We found that incorporation of small unencapsulated particles of activated charcoal would double both clearance and mass transfer of creatinine. It also maintained D/P values less than 0.6 even up to 8 hours. Small particles absorbed more than 10 times more creatinine per gram than large particles. Significant differences between encapsulated and unencapsulated large particles were not found. In summary, activated charcoal might double creatinine removal per exchange in CAPD. Animal studies of collodion encapsulated small particles and other sorbent-enzyme systems in CAPD dialysate solutions seem warranted.</p>","PeriodicalId":79208,"journal":{"name":"Clinical and experimental dialysis and apheresis","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1982-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3109/08860228209050816","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18166743","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Pharmacokinetics of digoxin in C.A.P.D.","authors":"M De Paepe, F Belpaire, Y Bogaerts","doi":"10.3109/08860228209050814","DOIUrl":"https://doi.org/10.3109/08860228209050814","url":null,"abstract":"<p><p>The peritoneal elimination of digoxin during C.A.P.D. was studied in five patients. The plasma half life of digoxin varied from 54 hours to 141 hours. Only 7 to 24 micrograms was eliminated via the peritoneal route during 3 to 4 days C.A.P.D. treatment. The total urinary elimination during the same period ranged from 11 to 57 micrograms. It is concluded that adjustment of dose is not necessary when starting C.A.P.D.</p>","PeriodicalId":79208,"journal":{"name":"Clinical and experimental dialysis and apheresis","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1982-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3109/08860228209050814","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35220368","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Subclavian hemodialysis using the two catheter single lumen approach.","authors":"A J Vaz","doi":"10.3109/08860228209050820","DOIUrl":"https://doi.org/10.3109/08860228209050820","url":null,"abstract":"<p><p>The subclavian vein has provided a useful vascular access for hemodialysis, both in acute as well as chronic renal failure. We were prompted to do 58 two catheter single lumen subclavian hemodialyses for the following reasons: (A) Marked obesity. (B) Patients with pre-existing aortic iliac synthetic vascular grafts. (C) Use of pre-existing hemodialysis equipment. (D) Decrease in recirculation and lack of high obligatory ultrafiltration as compared to single-needle hemodialysis.</p>","PeriodicalId":79208,"journal":{"name":"Clinical and experimental dialysis and apheresis","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1982-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3109/08860228209050820","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18166742","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Improved phosphate clearances with polycarbonate membranes.","authors":"L W Fleming, S W Hudson, W K Stewart","doi":"10.3109/08860228209049854","DOIUrl":"https://doi.org/10.3109/08860228209049854","url":null,"abstract":"<p><p>Clearance studies of urea, creatinine and inorganic phosphate have been carried out using polycarbonate dialysers on 20 occasions in two patients undergoing routine maintenance haemodialysis. Clearances were calculated using plasma concentrations and both measured blood flow and calculated plasma flow. Urea and creatinine clearances were comparable to those obtained with cellulose-based dialysers, but phosphate clearances were relatively increased, averaging over 70% of urea clearances. All clearances were reduced as TMP values increased, a feature at variance with the usual situation with cellulose membranes. Polycarbonate dialysers have the advantage of higher relative phosphate clearances in addition to the other advantages claimed for them.</p>","PeriodicalId":79208,"journal":{"name":"Clinical and experimental dialysis and apheresis","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1982-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3109/08860228209049854","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18196623","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}